GlassScriptPhysician profile
Moises Alejandro Virelles
NPI 1861457483
$21,087.19
in general payments reported to CMS, 2019-2025
39 companies · $232 in 2025
The $232 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $3,890 · 2021: $469 · 2022: $2,322 · 2023: $1,221 · 2024: $771 · 2025: $232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,078 · Education: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,077.62 |
| Education | $146.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Caldera Medical, INC | $16,602.15 | 2019-2024 | Desara |
| Medtronic, INC. | $1,809.84 | 2022-2024 | Interstim |
| Abbvie INC. | $462.90 | 2019-2025 | Botox, Lo Loestrin Fe, Orilissa |
| Astellas Pharma US INC | $345.13 | 2019-2024 | Veozah, Myrbetriq |
| Therapeuticsmd, INC. | $216.52 | 2019-2022 | |
| Pfizer INC. | $189.82 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $148.43 | 2021-2024 | |
| Axonics, INC. | $114.08 | 2023-2024 | Axonics |
| Hologic Sales and Service, LLC | $107.62 | 2021-2025 | Thinprep 2000 Processor, Aptima, Acessa Provu System |
| Boston Scientific Corporation | $79.91 | 2022-2025 | Solyx Sis System, Axonics |
| Millicent US INC | $77.67 | 2019-2025 | Intrarosa, Femring, Femlyv |
| Femselect INC. | $77.60 | 2025 | Enplace |
| Urovant Sciences INC | $65.55 | 2021-2022 | |
| Coopersurgical, INC. | $63.35 | 2019 | |
| Daiichi Sankyo INC. | $60.96 | 2019 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $53.97 | 2019-2023 | |
| Antares Pharma, INC. | $52.55 | 2021-2022 | |
| Novo Nordisk INC | $46.88 | 2019-2024 | Wegovy |
| Amag Pharmaceuticals, INC. | $46.22 | 2019 | |
| Allergan, INC. | $45.58 | 2021-2022 | |
| Radius Health, INC. | $42.50 | 2024 | Tymlos |
| Channel Medsystems, INC. | $37.91 | 2023 | |
| Covidien LP | $33.03 | 2019 | |
| Exact Sciences Corporation | $29.11 | 2024 | Cologuard Collection Kit |
| Avion Pharmaceuticals | $24.41 | 2021-2022 | |
| Integra Lifesciences Corporation | $23.85 | 2023 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Sumitomo Pharma America, INC. | $21.73 | 2023 | Gemtesa |
| Myovant Sciences INC. | $21.51 | 2021 | |
| Ibsa Pharma INC. | $20.94 | 2023 | Tirosint, Licart |
| Lupin INC. | $20.75 | 2021 | |
| Dexcom, INC. | $20.35 | 2025 | Dexcom G6 Transmitter |
| Laborie Medical Technologies Corp. | $17.94 | 2023 | |
| Bluewind Medical | $17.80 | 2025 | Revi |
| Cumberland Pharmaceuticals, INC. | $17.37 | 2021 | |
| Organon LLC | $16.80 | 2023 | Nexplanon |
| Baxter Healthcare | $16.49 | 2025 | Perclot |
| Shield Therapeutics INC | $14.04 | 2022 | |
| Ascend Therapeutics US, LLC | $12.46 | 2022 | |
| Agile Therapeutics, INC. | $11.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Moises Virelles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.